Percy Griffin holds a Ph.D. in Molecular Cell Biology from Washington University in St. Louis and an M.Sc. in Pharmacology from the University of Minnesota. Dr. Griffin focuses his practice on intellectual property law matters including support of validity, infringement, and patentability analysis in the biotechnology area. With a background in pharmacology, he is experienced in the drug discovery process. Other areas of expertise include:
Prior to joining MBHB Dr. Griffin served as Director of Scientific Engagement at the Alzheimer’s Association. In this role, he worked stakeholders from academia, industry, and regulators to advance research and treatment for Alzheimer’s and other dementias. He served as a spokesperson for the organization in that role. He held other roles in life science consulting and drug discovery.
Dr. Griffin’s graduate research focused on the intersection between circadian rhythms, neuroinflammation and Alzheimer’s diseases. At Washington University in St. Louis, Dr. Griffin was awarded the National Science Foundation Graduate Research Fellowship (NSF-GRFP) and the Neuroscience Scholars Program Fellowship (NSP) from the Society for Neuroscience (SfN). He completed the Science Communication Credential and served as a scientific editor and illustrator for InPrint, a publication editing service at Washington University. He also served as a consultant for the Biotechnology and Life Sciences Advisory Group.